Epoxide hydrolases are cellular enzymes that catalyze the conversion of epoxides to dihydrodiols. Because epoxides are highly reactive electrophiles, they are common ultimate toxins, mutagens, and carcinogens. The capability of epoxide hydrolases to convert these reactive intermediates to less reactive products places them among the most important endogenous means of protection against chemical toxins and carcinogens. The purpose of these studies is to examine several epoxide hydrolases, to compare and contrast their structural and catalytic properties, and to investigate their participation in the metabolism of toxic compounds. Understanding the nature of these multiple epoxide hydrolases and their participation in the deactivation of epoxide intermediates is essential to our ultimate understanding of mechanisms of chemical toxicity and carcinogenesis. The emphasis of these studies is on the examination of different epoxide hydrolases derived from different organs, species, and individuals. Of specific interest is the possible polymorphism of epoxide hydrolases in man. The existence of multiple enzyme forms in man may represent a significant genetically regulated determinant of different individual responses to chemical toxins and carcinogens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034455-06
Application #
3172148
Study Section
Toxicology Study Section (TOX)
Project Start
1983-05-01
Project End
1990-04-30
Budget Start
1988-05-01
Budget End
1989-04-30
Support Year
6
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Type
Overall Medical
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Luo, G; Guenthner, T M (1996) Covalent binding to DNA in vitro of 2',3'-oxides derived from allylbenzene analogs. Drug Metab Dispos 24:1020-7
Qato, M K; Guenthner, T M (1995) 32P-postlabeling analysis of adducts formed between DNA and safrole 2',3'-epoxide: absence of adduct formation in vivo. Toxicol Lett 75:201-7
Pirmohamed, M; Kitteringham, N R; Guenthner, T M et al. (1992) An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro. Biochem Pharmacol 43:1675-82
Luo, G; Qato, M K; Guenthner, T M (1992) Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases. Drug Metab Dispos 20:440-5
Hjelle, J T; Guenthner, T M; Bell, K et al. (1990) Inhibition of catalase and epoxide hydrolase by the renal cystogen 2-amino-4,5-diphenylthiazole and its metabolites. Toxicology 60:211-22
Qato, M K; Reinmund, S G; Guenthner, T M (1990) Production of monospecific antiserum to a cytosolic epoxide hydrolase from human liver. Biochem Pharmacol 39:293-300
Guenthner, T M; Hjelle, J T; Whalen, R (1989) Selective inhibition of cytosolic epoxide hydrolase activity in vitro by compounds that inhibit catalase. J Biochem Toxicol 4:241-9
Guenthner, T M; Qato, M; Whalen, R et al. (1989) Similarities between catalase and cytosolic epoxide hydrolase. Drug Metab Rev 20:733-48
Pezzuto, J M; Nanayakkara, N P; Compadre, C M et al. (1986) Characterization of bacterial mutagenicity mediated by 13-hydroxy-ent-kaurenoic acid (steviol) and several structurally-related derivatives and evaluation of potential to induce glutathione S-transferase in mice. Mutat Res 169:93-103
Guenthner, T M; Karnezis, T A (1986) Immunochemical characterization of human lung epoxide hydrolases. J Biochem Toxicol 1:67-81

Showing the most recent 10 out of 13 publications